Metropolitan Life Insurance Company (MetLife)’s Akamai AKAM Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio AKAM Stock Details AKAM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-6,082	Closed	-$661K	–	82
2024 Q1	$661K	Sell	6,082 -56	-0.9%	-$6.45K	0.03%	425
2023 Q4	$726K	Sell	6,138 -150	-2%	-$16.7K	0.03%	389
2023 Q3	$670K	Sell	6,288 -344	-5%	-$34.3K	0.03%	383
2023 Q2	$596K	Sell	6,632 -400	-6%	-$34.3K	0.03%	427
2023 Q1	$551K	Sell	7,032 -2,061	-23%	-$167K	0.03%	440
2022 Q4	$767K	Sell	9,093 -228	-2%	-$19.9K	0.03%	419
2022 Q3	$749K	Sell	9,321 -192	-2%	-$17.5K	0.04%	414
2022 Q2	$869K	Sell	9,513 -370	-4%	-$38.6K	0.04%	394
2022 Q1	$1.18M	Sell	9,883 -8,509	-46%	-$954K	0.04%	371
2021 Q4	$2.15M	Sell	18,392 -488	-3%	-$53.7K	0.03%	481
2021 Q3	$1.97M	Sell	18,880 -665	-3%	-$76K	0.03%	510
2021 Q2	$2.28M	Sell	19,545 -7,196	-27%	-$803K	0.03%	459
2021 Q1	$2.72M	Sell	26,741 -1,480	-5%	-$153K	0.04%	382
2020 Q4	$2.96M	Sell	28,221 -1,132	-4%	-$118K	0.04%	341
2020 Q3	$3.24M	Sell	29,353 -1,153	-4%	-$128K	0.06%	280
2020 Q2	$3.27M	Sell	30,506 -163	-0.5%	-$16.4K	0.06%	271
2020 Q1	$2.81M	Sell	30,669 -414	-1%	-$38.4K	0.06%	279
2019 Q4	$2.68M	Sell	31,083 -612	-2%	-$53.5K	0.04%	387
2019 Q3	$2.9M	Buy	31,695 +174	+0.6%	+$15.1K	0.05%	331
2019 Q2	$2.53M	Buy	31,521 +1,778	+6%	+$138K	0.04%	403
2019 Q1	$2.13M	Sell	29,743 -1,129	-4%	-$76.6K	0.04%	465
2018 Q4	$1.89M	Sell	30,872 -1,778	-5%	-$118K	0.04%	460
2018 Q3	$2.39M	Sell	32,650 -910	-3%	-$68.4K	0.04%	420
2018 Q2	$2.46M	Buy	33,560 +7,408	+28%	+$556K	0.04%	411
2018 Q1	$1.86M	Buy	26,152 +268	+1%	+$18.2K	0.03%	577
2017 Q4	$1.68M	Sell	25,884 -54,888	-68%	-$3.04M	0.02%	640
2017 Q3	$3.94M	Sell	80,772 -1,981	-2%	-$94.8K	0.02%	707
2017 Q2	$4.12M	Sell	82,753 -8,651	-9%	-$457K	0.03%	684
2017 Q1	$5.46M	Sell	91,404 -1,321	-1%	-$86.8K	0.04%	536
2016 Q4	$6.18M	Sell	92,725 -3,256	-3%	-$207K	0.04%	441
2016 Q3	$5.09M	Sell	95,981 -1,560	-2%	-$83.5K	0.04%	520
2016 Q2	$5.46M	Sell	97,541 -2,839	-3%	-$149K	0.04%	472
2016 Q1	$5.58M	Sell	100,380 -1,945	-2%	-$98.8K	0.04%	458
2015 Q4	$5.38M	Sell	102,325 -1,587	-2%	-$97.5K	0.04%	465
2015 Q3	$7.18M	Sell	103,912 -1,764	-2%	-$127K	0.05%	334
2015 Q2	$7.38M	Buy	105,676 +649	+0.6%	+$48.2K	0.05%	361
2015 Q1	$7.46M	Sell	105,027 -873	-0.8%	-$57.7K	0.05%	356
2014 Q4	$6.67M	Sell	105,900 -465	-0.4%	-$28K	0.05%	399
2014 Q3	$6.36M	Sell	106,365 -1,630	-2%	-$98K	0.05%	396
2014 Q2	$6.59M	Sell	107,995 -5,280	-5%	-$294K	0.05%	409
2014 Q1	$6.59M	Sell	113,275 -2,000	-2%	-$110K	0.05%	415
2013 Q4	$5.44M	Sell	115,275 -1,755	-1%	-$82.8K	0.04%	479
2013 Q3	$6.05M	Sell	117,030 -661	-0.6%	-$31.2K	0.05%	411
2013 Q2	$5.01M	Buy	+117,691	New	+$4.92M	0.04%	453

Other funds holding AKAM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Amundi Paris, France $367B AUM 31.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s AKAM Position: Q2 2024 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Akamai (AKAM) in Q2 2024, closing a stake of 6,082 shares — an estimated $661K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in AKAM in Q2 2013 and held it in 44 quarters. The position peaked at $7.46M in Q1 2015. 666 funds tracked by Wall St. Rank hold AKAM as of Q2 2024.

Metropolitan Life Insurance Company (MetLife) reported no remaining Akamai position as of Q2 2024 after selling out during the quarter.
Metropolitan Life Insurance Company (MetLife) sold 6,082 Akamai shares in Q2 2024, an estimated $661K.
Metropolitan Life Insurance Company (MetLife) first reported a position in Akamai in Q2 2013 and held it in 44 quarters.
Metropolitan Life Insurance Company (MetLife)'s Akamai position peaked at $7.46M in Q1 2015.
666 funds tracked by Wall St. Rank held Akamai as of Q2 2024.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.